Jeff Galvin, American Gene Technologies (AGT) (EP.67)

American Gene Technologies (AGT) CEO and Founder, Jeff Galvin, returns to BioTalk to share updates on their work for a potential functional cure for HIV, the growth of his company, and where they are going next.

Episode metadata supplied by the publisher feed · Published Oct 5, 2020

Embed this episode

Attribution link and audio player

NOW PLAYING

Jeff Galvin, American Gene Technologies (AGT) (EP.67)

0:00 37:47

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

Wild WinsDay Wild WinsDay Pump the hump with WILD WINSday 🐪💪: Your 3-minute weekly video boost for leadership, sales, marketing, and business breakthroughs to WIN the day!

Frequently Asked Questions

How long is this episode of BioTalk with Rich Bendis?

This episode is 37 minutes long.

When was this BioTalk with Rich Bendis episode published?

This episode was published on October 5, 2020.

Can I download this BioTalk with Rich Bendis episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!